Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

LifeVantage Corp (NASDAQ:LFVN)

13.52
Delayed Data
As of May 27
 -0.10 / -0.73%
Today’s Change
1.40
Today|||52-Week Range
13.96
+42.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$190.1M

Company Description

LifeVantage Corp. is a science-based company. It is engaged in the identification, research, development, manufacture and distribution of an advanced nutraceutical dietary supplement, including products Protandim, the Nrf2 Synergizer, Axio, anti-aging skin care product, LifeVantage TrueScience and Canine Health. The company currently focuses on oxidative stress solutions, particularly the activation of nuclear factor which relates to cardiovascular, central nervous system, inflammatory and metabolic diseases, and other health related disorders. LifeVantage was founded in June 1988 and is headquartered in Sandy, UT.

Contact Information

LifeVantage Corp.
9785 South Monroe Street
Sandy Utah 84070
P:(866) 460-7241
Investor Relations:

Employees

Shareholders

Mutual fund holders4.97%
Individual stakeholders2.05%
Other institutional14.54%

Top Executives

Darren JensenPresident, Chief Executive Officer & Director
Robert M. UrbanChief Operating Officer
Mark JaggiChief Financial Officer & Treasurer
Eric E. MarchantVice President-Compliance
David Whitney BrownPresident-LifeVantage Network